OrganiGram Holdings Inc (TO:OGI) — Market Cap & Net Worth
Market Cap & Net Worth: OrganiGram Holdings Inc (OGI)
OrganiGram Holdings Inc (TO:OGI) has a market capitalization of $148.68 Million (CA$205.53 Million) as of September 17, 2026. Listed on the TO stock exchange, this Canada-based company holds position #17768 globally and #577 in its home market, demonstrating a -8.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OrganiGram Holdings Inc's stock price CA$1.46 by its total outstanding shares 140775022 (140.78 Million). Also see OGI asset base for a full breakdown of the balance sheet.
OrganiGram Holdings Inc Market Cap History: 2015 to 2026
OrganiGram Holdings Inc's market capitalization history from 2015 to 2026. Data shows change from $382.90 Million to $148.68 Million (-3.19% CAGR). Also see OGI cash generation efficiency for how efficiently the company converts equity into cash flow.
OrganiGram Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OrganiGram Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check OrganiGram Holdings Inc stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.91x
OrganiGram Holdings Inc's market cap is 0.91 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.18 Billion | $6.13 Million | $846.66K | 192.77x | 1395.22x |
| 2017 | $1.67 Billion | $5.39 Million | -$10.89 Million | 309.91x | N/A |
| 2018 | $1.97 Billion | $12.43 Million | $20.51 Million | 158.62x | 96.11x |
| 2019 | $1.30 Billion | $80.41 Million | -$9.54 Million | 16.16x | N/A |
| 2020 | $688.40 Million | $86.80 Million | -$136.16 Million | 7.93x | N/A |
| 2021 | $904.29 Million | $79.16 Million | -$130.70 Million | 11.42x | N/A |
| 2022 | $448.07 Million | $145.81 Million | -$14.28 Million | 3.07x | N/A |
| 2023 | $175.16 Million | $149.21 Million | -$229.48 Million | 1.17x | N/A |
| 2024 | $234.22 Million | $159.84 Million | -$45.44 Million | 1.47x | N/A |
| 2025 | $235.24 Million | $259.18 Million | -$24.76 Million | 0.91x | N/A |
Competitor Companies of OGI by Market Capitalization
Companies near OrganiGram Holdings Inc in the global market cap rankings as of September 17, 2026. Review tangible net worth ratio of OrganiGram Holdings Inc to assess the quality of the company's equity after excluding intangible assets.
Key companies related to OrganiGram Holdings Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
OrganiGram Holdings Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, OrganiGram Holdings Inc's market cap moved from $382.90 Million to $ 148.68 Million, with a yearly change of -3.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$148.68 Million | -36.80% |
| 2025 | CA$235.24 Million | +0.43% |
| 2024 | CA$234.22 Million | +33.72% |
| 2023 | CA$175.16 Million | -60.91% |
| 2022 | CA$448.07 Million | -50.45% |
| 2021 | CA$904.29 Million | +31.36% |
| 2020 | CA$688.40 Million | -47.02% |
| 2019 | CA$1.30 Billion | -34.09% |
| 2018 | CA$1.97 Billion | +18.05% |
| 2017 | CA$1.67 Billion | +41.38% |
| 2016 | CA$1.18 Billion | +208.51% |
| 2015 | CA$382.90 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of OrganiGram Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $148.68 Million USD |
| MoneyControl | $148.68 Million USD |
| MarketWatch | $148.68 Million USD |
| marketcap.company | $148.68 Million USD |
| Reuters | $148.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About OrganiGram Holdings Inc
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Ediso… Read more